Inhibrx Net Debt from 2010 to 2024

INBX Stock

USD 14.86 0.78 5.54%

Inhibrx Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Inhibrx minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2019-03-31

Previous Quarter

-224.7 M

Current Value

-194.5 M

Quarterly Volatility

69.3 M

Covid

Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.

Check out the analysis of Inhibrx Correlation against competitors.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Net Debt Growth Pattern

Below is the plot of the Net Debt of Inhibrx over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Inhibrx's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Inhibrx Net Debt Regression Statistics

	Arithmetic Mean	(20,593,990)
	Coefficient Of Variation	(185.95)
	Mean Deviation	33,739,187
	Median	1,190,000
	Standard Deviation	38,295,216
	Sample Variance	1466.5T
	Range	121.4M
	R-Value	(0.71)
	Mean Square Error	786.4T
	R-Squared	0.50
	Significance	0
	Slope	(6,067,614)
	Total Sum of Squares	20531.3T

Inhibrx Net Debt History

	2024	-64.4 M
	2023	-67.8 M
	2022	-71.8 M
	2021	-60.8 M
	2020	-91.2 M
	2019	30.2 M
	2018	7.4 M

Other Fundumenentals of Inhibrx

Net Debt To E B I T D A

Inhibrx Net Debt component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Common Stock	Long Term Debt Total	Capital Surpluse
Net Tangible Assets		-0.72	0.65	0.81	0.14	0.81	0.98	-0.71	-0.94	0.68	-0.02	0.5	0.84	-0.59	0.82	-0.78	-0.49	0.91	0.91	0.67	0.63
Retained Earnings	-0.72		-0.63	-0.97	-0.17	-0.97	-0.7	0.57	0.76	-0.97	0.26	-0.87	-0.94	0.75	-0.96	0.59	0.81	-0.83	-0.83	-0.97	-0.9
Accounts Payable	0.65	-0.63		0.69	0.68	0.71	0.76	-0.3	-0.85	0.56	-0.2	0.6	0.66	-0.72	0.68	-0.82	-0.3	0.71	0.71	0.5	0.52
Total Current Assets	0.81	-0.97	0.69		0.18	1.0	0.81	-0.62	-0.85	0.97	-0.36	0.86	0.99	-0.76	1.0	-0.71	-0.72	0.86	0.86	0.96	0.9
Property Plant Equipment	0.14	-0.17	0.68	0.18		0.21	0.28	0.46	-0.38	0.07	-0.12	0.21	0.1	-0.68	0.17	-0.63	0.06	0.11	0.11	-0.03	0.0
Total Assets	0.81	-0.97	0.71	1.0	0.21		0.81	-0.6	-0.86	0.97	-0.36	0.87	0.99	-0.78	1.0	-0.73	-0.72	0.85	0.85	0.95	0.89
Total Stockholder Equity	0.98	-0.7	0.76	0.81	0.28	0.81		-0.65	-0.98	0.67	-0.08	0.53	0.83	-0.65	0.82	-0.87	-0.41	0.9	0.9	0.63	0.62
Current Deferred Revenue	-0.71	0.57	-0.3	-0.62	0.46	-0.6	-0.65		0.59	-0.59	-0.08	-0.39	-0.67	0.04	-0.64	0.27	0.47	-0.76	-0.76	-0.64	-0.61
Net Debt	-0.94	0.76	-0.85	-0.85	-0.38	-0.86	-0.98	0.59		-0.72	0.16	-0.62	-0.87	0.73	-0.86	0.89	0.45	-0.91	-0.91	-0.68	-0.67
Long Term Debt	0.68	-0.97	0.56	0.97	0.07	0.97	0.67	-0.59	-0.72		-0.43	0.9	0.96	-0.71	0.97	-0.59	-0.75	0.76	0.76	0.99	0.93
Net Receivables	-0.02	0.26	-0.2	-0.36	-0.12	-0.36	-0.08	-0.08	0.16	-0.43		-0.42	-0.38	0.33	-0.38	0.31	0.15	0.08	0.08	-0.38	-0.28
Total Liab	0.5	-0.87	0.6	0.86	0.21	0.87	0.53	-0.39	-0.62	0.9	-0.42		0.83	-0.77	0.86	-0.51	-0.49	0.69	0.69	0.87	0.95
Net Invested Capital	0.84	-0.94	0.66	0.99	0.1	0.99	0.83	-0.67	-0.87	0.96	-0.38	0.83		-0.72	0.99	-0.7	-0.69	0.87	0.87	0.95	0.89
Short Long Term Debt	-0.59	0.75	-0.72	-0.76	-0.68	-0.78	-0.65	0.04	0.73	-0.71	0.33	-0.77	-0.72		-0.76	0.81	0.39	-0.6	-0.6	-0.63	-0.67
Net Working Capital	0.82	-0.96	0.68	1.0	0.17	1.0	0.82	-0.64	-0.86	0.97	-0.38	0.86	0.99	-0.76		-0.73	-0.69	0.86	0.86	0.95	0.9
Short Term Debt	-0.78	0.59	-0.82	-0.71	-0.63	-0.73	-0.87	0.27	0.89	-0.59	0.31	-0.51	-0.7	0.81	-0.73		0.25	-0.65	-0.65	-0.5	-0.47
Deferred Long Term Liab	-0.49	0.81	-0.3	-0.72	0.06	-0.72	-0.41	0.47	0.45	-0.75	0.15	-0.49	-0.69	0.39	-0.69	0.25		-0.54	-0.54	-0.79	-0.56
Capital Stock	0.91	-0.83	0.71	0.86	0.11	0.85	0.9	-0.76	-0.91	0.76	0.08	0.69	0.87	-0.6	0.86	-0.65	-0.54		1.0	0.76	0.81
Common Stock	0.91	-0.83	0.71	0.86	0.11	0.85	0.9	-0.76	-0.91	0.76	0.08	0.69	0.87	-0.6	0.86	-0.65	-0.54	1.0		0.76	0.81
Long Term Debt Total	0.67	-0.97	0.5	0.96	-0.03	0.95	0.63	-0.64	-0.68	0.99	-0.38	0.87	0.95	-0.63	0.95	-0.5	-0.79	0.76	0.76		0.93
Capital Surpluse	0.63	-0.9	0.52	0.9	0.0	0.89	0.62	-0.61	-0.67	0.93	-0.28	0.95	0.89	-0.67	0.9	-0.47	-0.56	0.81	0.81	0.93

Click cells to compare fundamentals

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-67.8 M	-64.4 M
Net Debt To EBITDA	0.33	0.21

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inhibrx Net Debt from 2010 to 2024

Latest Inhibrx's Net Debt Growth Pattern

Inhibrx Net Debt Regression Statistics

Inhibrx Net Debt History

Other Fundumenentals of Inhibrx

Inhibrx Net Debt component correlations

About Inhibrx Financial Statements

Also Currently Popular

Additional Tools for Inhibrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY